CSF2 and metastatic colorectal cancer: Similarly, Gottschalk and colleagues used a granulocyte-macrophage colony-stimulating factor (GM-CSF)/IL-18 ICR to sustain the functionality of CAR T cells targeting human epidermal growth factor receptor 2, a metastatic colorectal cancer target27.